1. Home
  2. MRAM vs RPTX Comparison

MRAM vs RPTX Comparison

Compare MRAM & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Everspin Technologies Inc.

MRAM

Everspin Technologies Inc.

HOLD

Current Price

$8.96

Market Cap

183.3M

Sector

Technology

ML Signal

HOLD

Logo Repare Therapeutics Inc.

RPTX

Repare Therapeutics Inc.

HOLD

Current Price

$2.16

Market Cap

92.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRAM
RPTX
Founded
2008
2016
Country
United States
Canada
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
183.3M
92.4M
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
MRAM
RPTX
Price
$8.96
$2.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$10.50
$3.00
AVG Volume (30 Days)
154.6K
530.7K
Earning Date
11-05-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$53,642,000.00
$11,870,000.00
Revenue This Year
$11.00
N/A
Revenue Next Year
$9.39
$9.55
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.34
$0.89
52 Week High
$12.27
$2.30

Technical Indicators

Market Signals
Indicator
MRAM
RPTX
Relative Strength Index (RSI) 51.45 55.66
Support Level $8.38 $2.11
Resistance Level $9.74 $2.27
Average True Range (ATR) 0.42 0.06
MACD 0.05 -0.01
Stochastic Oscillator 56.24 28.13

Price Performance

Historical Comparison
MRAM
RPTX

About MRAM Everspin Technologies Inc.

Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC).

About RPTX Repare Therapeutics Inc.

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.

Share on Social Networks: